Cargando…

High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease

Patients with marked calcification of the basal ganglia and cerebellum have traditionally been referred to as having Fahr's disease, but the nomenclature has been criticized for including heterogeneous etiology. We describe 3 patients with idiopathic bilateral striatopallidodentate calcinosis (...

Descripción completa

Detalles Bibliográficos
Autores principales: Hozumi, Isao, Kohmura, Akihiro, Kimura, Akio, Hasegawa, Tatsuya, Honda, Akiko, Hayashi, Yuichi, Hashimoto, Kazunori, Yamada, Megumi, Sakurai, Takeo, Tanaka, Yuji, Satoh, Masahiko, Inuzuka, Takashi
Formato: Texto
Lenguaje:English
Publicado: S. Karger AG 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905580/
https://www.ncbi.nlm.nih.gov/pubmed/20671856
http://dx.doi.org/10.1159/000313920
_version_ 1782183978382393344
author Hozumi, Isao
Kohmura, Akihiro
Kimura, Akio
Hasegawa, Tatsuya
Honda, Akiko
Hayashi, Yuichi
Hashimoto, Kazunori
Yamada, Megumi
Sakurai, Takeo
Tanaka, Yuji
Satoh, Masahiko
Inuzuka, Takashi
author_facet Hozumi, Isao
Kohmura, Akihiro
Kimura, Akio
Hasegawa, Tatsuya
Honda, Akiko
Hayashi, Yuichi
Hashimoto, Kazunori
Yamada, Megumi
Sakurai, Takeo
Tanaka, Yuji
Satoh, Masahiko
Inuzuka, Takashi
author_sort Hozumi, Isao
collection PubMed
description Patients with marked calcification of the basal ganglia and cerebellum have traditionally been referred to as having Fahr's disease, but the nomenclature has been criticized for including heterogeneous etiology. We describe 3 patients with idiopathic bilateral striatopallidodentate calcinosis (IBSPDC). The patients were a 24-year-old man with mental deterioration, a 57-year-old man with parkinsonism and dementia, and a 76-year-old woman with dementia and mild parkinsonism. The former 2 patients showed severe calcification of the basal ganglia and cerebellum, and the latter patient showed severe calcification of the cerebellum. We found significantly increased levels of copper (Cu), zinc (Zn), iron (Fe) and magnesium (Mg), using inductively coupled plasma mass spectrometry in the CSF of all these 3 patients. The increased levels of Cu, Zn, Fe and Mg reflect the involvement of metabolism of several metals and/or metal-binding proteins during the progression of IBSPDC. More numerous patients with IBSPDC should be examined in other races to clarify the common mechanism of the disease and to investigate the specific treatment.
format Text
id pubmed-2905580
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher S. Karger AG
record_format MEDLINE/PubMed
spelling pubmed-29055802010-07-29 High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease Hozumi, Isao Kohmura, Akihiro Kimura, Akio Hasegawa, Tatsuya Honda, Akiko Hayashi, Yuichi Hashimoto, Kazunori Yamada, Megumi Sakurai, Takeo Tanaka, Yuji Satoh, Masahiko Inuzuka, Takashi Case Rep Neurol Published: May 2010 Patients with marked calcification of the basal ganglia and cerebellum have traditionally been referred to as having Fahr's disease, but the nomenclature has been criticized for including heterogeneous etiology. We describe 3 patients with idiopathic bilateral striatopallidodentate calcinosis (IBSPDC). The patients were a 24-year-old man with mental deterioration, a 57-year-old man with parkinsonism and dementia, and a 76-year-old woman with dementia and mild parkinsonism. The former 2 patients showed severe calcification of the basal ganglia and cerebellum, and the latter patient showed severe calcification of the cerebellum. We found significantly increased levels of copper (Cu), zinc (Zn), iron (Fe) and magnesium (Mg), using inductively coupled plasma mass spectrometry in the CSF of all these 3 patients. The increased levels of Cu, Zn, Fe and Mg reflect the involvement of metabolism of several metals and/or metal-binding proteins during the progression of IBSPDC. More numerous patients with IBSPDC should be examined in other races to clarify the common mechanism of the disease and to investigate the specific treatment. S. Karger AG 2010-05-07 /pmc/articles/PMC2905580/ /pubmed/20671856 http://dx.doi.org/10.1159/000313920 Text en Copyright © 2010 by S. Karger AG, Basel http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial-No-Derivative-Works License (http://creativecommons.org/licenses/by-nc-nd/3.0/). Users may download, print and share this work on the Internet for noncommercial purposes only, provided the original work is properly cited, and a link to the original work on http://www.karger.com and the terms of this license are included in any shared versions.
spellingShingle Published: May 2010
Hozumi, Isao
Kohmura, Akihiro
Kimura, Akio
Hasegawa, Tatsuya
Honda, Akiko
Hayashi, Yuichi
Hashimoto, Kazunori
Yamada, Megumi
Sakurai, Takeo
Tanaka, Yuji
Satoh, Masahiko
Inuzuka, Takashi
High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease
title High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease
title_full High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease
title_fullStr High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease
title_full_unstemmed High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease
title_short High Levels of Copper, Zinc, Iron and Magnesium, but not Calcium, in the Cerebrospinal Fluid of Patients with Fahr's Disease
title_sort high levels of copper, zinc, iron and magnesium, but not calcium, in the cerebrospinal fluid of patients with fahr's disease
topic Published: May 2010
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2905580/
https://www.ncbi.nlm.nih.gov/pubmed/20671856
http://dx.doi.org/10.1159/000313920
work_keys_str_mv AT hozumiisao highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT kohmuraakihiro highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT kimuraakio highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT hasegawatatsuya highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT hondaakiko highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT hayashiyuichi highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT hashimotokazunori highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT yamadamegumi highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT sakuraitakeo highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT tanakayuji highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT satohmasahiko highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease
AT inuzukatakashi highlevelsofcopperzincironandmagnesiumbutnotcalciuminthecerebrospinalfluidofpatientswithfahrsdisease